{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:18:13Z","timestamp":1777033093801,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06806-2","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T03:01:56Z","timestamp":1699930916000},"page":"251-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-4074","authenticated-orcid":false,"given":"Ana","family":"Martins","sequence":"first","affiliation":[]},{"given":"Daniela","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Rafaela","family":"Nicolau","sequence":"additional","affiliation":[]},{"given":"Teresa Martins","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"Bernardo","sequence":"additional","affiliation":[]},{"given":"L\u00facia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Pimenta","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"6806_CR1","doi-asserted-by":"publisher","unstructured":"Husni E, Michael M (2018) Oxford textbook of psoriatic arthritis: epidemiology of psoriatic arthritis. Oxford University, pp 15\u201318.\u00a0https:\/\/doi.org\/10.1093\/med\/9780198737582.001.0001","DOI":"10.1093\/med\/9780198737582.001.0001"},{"issue":"1","key":"6806_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi F, Calov M, Kristensen LE et al (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(1):251\u2013265 e219","journal-title":"J Am Acad Dermatol"},{"key":"6806_CR3","doi-asserted-by":"publisher","unstructured":"Ocampo DV, Gladman D (2019) Psoriatic arthritis. F1000Res 8:F1000 Faculty Rev-1665.\u00a0https:\/\/doi.org\/10.12688\/f1000research.19144.1","DOI":"10.12688\/f1000research.19144.1"},{"issue":"1","key":"6806_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","volume":"48","author":"L Scotti","year":"2018","unstructured":"Scotti L, Franchi M, Marchesoni A, Corrao G (2018) Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 48(1):28\u201334","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"6806_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","volume":"41","author":"ME Husni","year":"2015","unstructured":"Husni ME (2015) Comorbidities in psoriatic arthritis. Rheum Dis Clin N Am 41(4):677\u2013698","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"6806_CR6","first-page":"318","volume":"31","author":"F Bandinelli","year":"2013","unstructured":"Bandinelli F, Prignano F, Bonciani D et al (2013) Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol 31(2):318\u2013319","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"6806_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.130797","volume":"41","author":"E McDonough","year":"2014","unstructured":"McDonough E, Ayearst R, Eder L et al (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887\u2013896","journal-title":"J Rheumatol"},{"issue":"16","key":"6806_CR8","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.3346\/jkms.2021.36.e99","volume":"36","author":"H Kim","year":"2021","unstructured":"Kim H, Kim SH, Cho YJ (2021) Combined effects of depression and chronic disease on the risk of mortality: the Korean longitudinal study of aging (2006-2016). J Korean Med Sci 36(16):e99","journal-title":"J Korean Med Sci"},{"issue":"5","key":"6806_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00403-019-01906-z","volume":"311","author":"A Duvetorp","year":"2019","unstructured":"Duvetorp A, Ostergaard M, Skov L et al (2019) Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Arch Dermatol Res 311(5):351\u2013360","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"6806_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/acr.21725","volume":"64","author":"K Kotsis","year":"2012","unstructured":"Kotsis K, Voulgari PV, Tsifetaki N et al (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593\u20131601","journal-title":"Arthritis Care Res"},{"issue":"5","key":"6806_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jpain.2016.01.474","volume":"17","author":"M Hermesdorf","year":"2016","unstructured":"Hermesdorf M, Berger K, Baune BT, Wellmann J, Ruscheweyh R, Wersching H (2016) Pain sensitivity in patients with major depression: differential effect of pain sensitivity measures, somatic cofactors, and disease characteristics. J Pain 17(5):606\u2013616","journal-title":"J Pain"},{"issue":"12","key":"6806_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jpain.2016.08.007","volume":"17","author":"T Thompson","year":"2016","unstructured":"Thompson T, Correll CU, Gallop K, Vancampfort D, Stubbs B (2016) Is pain perception altered in people with depression? A systematic review and meta-analysis of experimental pain research. J Pain 17(12):1257\u20131272","journal-title":"J Pain"},{"key":"6806_CR13","doi-asserted-by":"publisher","first-page":"152188","DOI":"10.1016\/j.semarthrit.2023.152188","volume":"60","author":"SS Zhao","year":"2023","unstructured":"Zhao SS, Holmes MV, Alam U (2023) Disentangling the relationship between depression and chronic widespread pain: a Mendelian randomisation study. Semin Arthritis Rheum 60:152188","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"6806_CR14","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J et al (2017) Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 76(11):1906\u20131910","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6806_CR15","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/acr.24593","volume":"74","author":"A Wong","year":"2022","unstructured":"Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V (2022) Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res 74(9):1430\u20131434","journal-title":"Arthritis Care Res"},{"issue":"4","key":"6806_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0022-3999(02)00313-6","volume":"53","author":"W Katon","year":"2002","unstructured":"Katon W, Ciechanowski P (2002) Impact of major depression on chronic medical illness. J Psychosom Res 53(4):859\u2013863","journal-title":"J Psychosom Res"},{"issue":"14","key":"6806_CR17","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","volume":"160","author":"MR DiMatteo","year":"2000","unstructured":"DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101\u20132107","journal-title":"Arch Intern Med"},{"issue":"4","key":"6806_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jid.2016.11.032","volume":"137","author":"RT Lewinson","year":"2017","unstructured":"Lewinson RT, Vallerand IA, Lowerison MW et al (2017) Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study. J Invest Dermatol 137(4):828\u2013835","journal-title":"J Invest Dermatol"},{"issue":"8","key":"6806_CR19","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"20","key":"6806_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 310(20):2191\u20132194","journal-title":"JAMA."},{"issue":"1","key":"6806_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","volume":"42","author":"C Herrmann","year":"1997","unstructured":"Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res 42(1):17\u201341","journal-title":"J Psychosom Res"},{"issue":"4","key":"6806_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jpsychores.2010.04.006","volume":"69","author":"C Brennan","year":"2010","unstructured":"Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A (2010) The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res 69(4):371\u2013378","journal-title":"J Psychosom Res"},{"issue":"6","key":"6806_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J et al (2009) Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6806_CR24","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7(4):R796\u2013R806","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"6806_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2):244\u2013257","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 11","key":"6806_CR26","first-page":"S47","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res 63(Suppl 11):S47\u2013S58","journal-title":"Arthritis Care Res"},{"issue":"2","key":"6806_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137\u2013145","journal-title":"Arthritis Rheum"},{"issue":"Suppl 11","key":"6806_CR28","first-page":"S64","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ (2011) Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res 63(Suppl 11):S64\u2013S85","journal-title":"Arthritis Care Res"},{"issue":"6","key":"6806_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38(6):727\u2013735","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6806_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landewe R, Lie E et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6806_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van\u2019t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum 39(1):34\u201340","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6806_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/acr.23333","volume":"70","author":"C Ballegaard","year":"2018","unstructured":"Ballegaard C, Hojgaard P, Dreyer L et al (2018) Impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study. Arthritis Care Res 70(4):592\u2013599","journal-title":"Arthritis Care Res"},{"issue":"2","key":"6806_CR33","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/ar2670","volume":"11","author":"AA Saad","year":"2009","unstructured":"Saad AA, Ashcroft DM, Watson KD et al (2009) Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Res Ther 11(2):R52","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"6806_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","volume":"47","author":"ME Husni","year":"2017","unstructured":"Husni ME, Merola JF, Davin S (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351\u2013360","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6806_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 139(3):230\u2013239","journal-title":"J Affect Disord"},{"issue":"12","key":"6806_CR36","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4088\/JCP.15m10267","volume":"77","author":"MS Cepeda","year":"2016","unstructured":"Cepeda MS, Stang P, Makadia R (2016) Depression is associated with high levels of C-reactive protein and low levels of fractional exhaled nitric oxide: results from the 2007-2012 National Health and Nutrition Examination Surveys. J Clin Psychiatry 77(12):1666\u20131671","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"6806_CR37","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 36(12):2452\u20132459","journal-title":"Neuropsychopharmacology."},{"issue":"4","key":"6806_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrrheum.2011.2","volume":"7","author":"RR Edwards","year":"2011","unstructured":"Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA (2011) Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol 7(4):216\u2013224","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6806_CR39","first-page":"40","volume":"40","author":"HL Rogers","year":"2015","unstructured":"Rogers HL, Brotherton HT, de Luis A, Olivera-Plaza SL, Cordoba-Patino AF, Pena-Altamar ML (2015) Depressive symptoms are independently associated with pain perception in Colombians with rheumatoid arthritis. Acta Reumatol Port 40(1):40\u201349","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"6806_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr.23330","volume":"70","author":"L Howells","year":"2018","unstructured":"Howells L, Chisholm A, Cotterill S, Chinoy H, Warren RB, Bundy C (2018) Impact of disease severity, illness beliefs, and coping strategies on outcomes in psoriatic arthritis. Arthritis Care Res 70(2):295\u2013302","journal-title":"Arthritis Care Res"},{"key":"6806_CR41","doi-asserted-by":"crossref","unstructured":"Bournia VK, Tektonidou MG, Vassilopoulos D et al (2020) Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease. RMD Open 6(3):e001303","DOI":"10.1136\/rmdopen-2020-001303"}],"updated-by":[{"DOI":"10.1007\/s10067-024-06875-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06806-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06806-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06806-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T07:12:39Z","timestamp":1706598759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06806-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6806"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06806-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-024-06875-x","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-024-06875-x","URL":"https:\/\/doi.org\/10.1007\/s10067-024-06875-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}